Publications by authors named "W C Schultz"

Introduction: Although the etiology of depression is incredibly complex, the narrative that it is caused by a simple "chemical imbalance" persists in lay settings. We sought to understand where people are exposed to this explanation (i.e.

View Article and Find Full Text PDF

Correctional Service Providers (CSP), including Correctional officers (COs), are key front-line figures in prisons globally, with responsibility for a wide range of daily prison operations. Over the past decade, research on prison staff has massively grown. However, the portrait this scholarship draws is concerning.

View Article and Find Full Text PDF

Sickle cell anemia (SCA) is recognized globally, but little is known about affected Hispanic populations. In partnership with Dominican Republic, a Hispanic Caribbean Island with a large SCA population, a TCD screening program provided hydroxyurea to children with conditional velocities. Building local capacity, ten Dominican medical graduates were certified in TCD examinations and trained in hydroxyurea management.

View Article and Find Full Text PDF

Risk is a fundamental factor affecting individual and social economic decisions, but its neural correlates are largely unexplored in the social domain. The amygdala, together with the dorsal anterior cingulate cortex (dACC), is thought to play a central role in risk taking. Here, we investigated in human volunteers (n=20; 11 females) how risk (defined as variance of reward probability distributions) in a social situation affects decisions and concomitant neural activity as measured with fMRI.

View Article and Find Full Text PDF
Article Synopsis
  • Pazopanib, a medication used for certain cancers, may pose a risk of acute coronary syndrome (ACS), but its direct link to heart issues hasn't been definitively established.
  • A 65-year-old woman with metastatic leiomyosarcoma experienced ACS after being on pazopanib for 8 months, and prior tests showed only mild coronary artery disease.
  • This case emphasizes the need for careful heart risk assessments for patients taking pazopanib, considering the potential for serious cardiovascular complications.
View Article and Find Full Text PDF